Buzdar AU - Search Results

1

Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.

Arun B, Valero V, Liu D, Brewster A, Green M, Gutierrez-Barrera A, Akar U, Rivera E, Esteva FJ, Buzdar AU, Hortobagyi GN, Sneige N. Arun B, et al. Among authors: buzdar au. Cancer Prev Res (Phila). 2012 Feb;5(2):276-82. doi: 10.1158/1940-6207.CAPR-11-0346. Epub 2011 Nov 18. Cancer Prev Res (Phila). 2012. PMID: 22102688

2

Efficacy of anastrozole in male breast cancer.

Giordano SH, Valero V, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: buzdar au. Am J Clin Oncol. 2002 Jun;25(3):235-7. doi: 10.1097/00000421-200206000-00006. Am J Clin Oncol. 2002. PMID: 12040279

3

Breast cancer in men.

Giordano SH, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: buzdar au. Ann Intern Med. 2002 Oct 15;137(8):678-87. doi: 10.7326/0003-4819-137-8-200210150-00013. Ann Intern Med. 2002. PMID: 12379069 Review.

4

Is breast cancer survival improving?

Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Giordano SH, et al. Among authors: buzdar au. Cancer. 2004 Jan 1;100(1):44-52. doi: 10.1002/cncr.11859. Cancer. 2004. PMID: 14692023 Free article.

5

Women age < or = 35 years with primary breast carcinoma: disease features at presentation.

Gonzalez-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, Theriault R, Booser D, Buzdar AU, Hortobagyi GN, Arun B. Gonzalez-Angulo AM, et al. Among authors: buzdar au. Cancer. 2005 Jun 15;103(12):2466-72. doi: 10.1002/cncr.21070. Cancer. 2005. PMID: 15852360 Free article.

6

Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.

Mazouni C, Hall A, Broglio K, Fritsche H, Andre F, Esteva FJ, Hortobagyi GN, Buzdar AU, Pusztai L, Cristofanilli M. Mazouni C, et al. Among authors: buzdar au. Cancer. 2007 Feb 1;109(3):496-501. doi: 10.1002/cncr.22418. Cancer. 2007. PMID: 17149760 Free article. Clinical Trial.

7

Update on endocrine therapy for breast cancer.

Buzdar AU, Hortobagyi G. Buzdar AU, et al. Clin Cancer Res. 1998 Mar;4(3):527-34. Clin Cancer Res. 1998. PMID: 9533518 Review.

8

Anastrozole (Arimidex), a new aromatase inhibitor for advanced breast cancer: mechanism of action and role in management.

Hortobagyi GN, Buzdar AU. Hortobagyi GN, et al. Among authors: buzdar au. Cancer Invest. 1998;16(6):385-90. doi: 10.3109/07357909809115778. Cancer Invest. 1998. PMID: 9679529 Review. No abstract available.

9

Breast cancer.

Buzdar AU, Hortobagyi GN. Buzdar AU, et al. Cancer Chemother Biol Response Modif. 1999;18:435-69. Cancer Chemother Biol Response Modif. 1999. PMID: 10800497 Review. No abstract available.

10

Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.

Eralp Y, Smith TL, Altundağ K, Kau SW, Litton J, Valero V, Buzdar A, Hortobagyi GN, Arun B. Eralp Y, et al. J Cancer Res Clin Oncol. 2009 Jan;135(1):141-8. doi: 10.1007/s00432-008-0428-9. Epub 2008 Jun 26. J Cancer Res Clin Oncol. 2009. PMID: 18581139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters